FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

331255004: Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674119010 Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674121017 Benzocaine 10 mg and cetylpyridinium chloride 1.4 mg oromucosal lozenge en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Compound anesthetic topical preparation false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anesthetic (substance) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Product containing cetylpyridinium (medicinal product) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Product containing benzocaine (medicinal product) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Benzocaine (substance) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cetylpyridinium false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cationic surfactant (substance) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anti-infectieux cutané false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Product containing benzocaine and cetylpyridinium (medicinal product) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has manufactured dose form forme pharmaceutique pour usage oromucosal et/ou gingival false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Product containing cetylpyridinium in oropharyngeal dose form (medicinal product form) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Product containing benzocaine in oropharyngeal dose form (medicinal product form) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has manufactured dose form A type of solid dose form intended to dissolve or disintegrate slowly in the mouth while being sucked. false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has manufactured dose form Oromucosal lozenge true Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Product manufactured as oromucosal dose form (product) false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Benzocaine (substance) true Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Lozenge true Inferred relationship Some 2
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength numerator value 1.4 false Inferred relationship Some 2
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Lozenge true Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 2
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength numerator value dix false Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Cetylpyridinium chloride (substance) true Inferred relationship Some 2
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has unit of presentation Lozenge true Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Cetylpyridinium chloride (substance) true Inferred relationship Some 2
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Benzocaine (substance) true Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Count of base of active ingredient deux false Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) Is a Benzocaine and cetylpyridinium only product in oromucosal dose form true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start